RecruitingNCT06889805

HDV Screening Study

Universal Screening for Hepatitis Delta Virus (HDV) in Individuals Living with HIV/HBV Coinfection and HBV-related HCC


Sponsor

Grace Lai Hung Wong

Enrollment

300 participants

Start Date

Feb 15, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This is a territory-wide cross-sectional study of all individuals living with HIV/HBV coinfection and HBV-related HCC.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Individuals with HIV infection, i.e. anti-HIV or HIV RNA positive; AND
  • Individuals with chronic hepatitis B, i.e. hepatitis B surface antigen (HBsAg) or HBV DNA positive for two times at least 6 months apart; AND
  • Aged 18 years old or above.
  • Written or verbal consent obtained

Exclusion Criteria2

  • Refusal to consent
  • Age \< 18 years

Locations(1)

The Chinese University of Hong Kong

Hong Kong, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06889805